Robert T. Lyons
31Patents
9h-index
20Co-inventors
75Inventor score
Filing activity: Jan 20, 1984 → Aug 19, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5616342A | Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof | Human Necessities | 55 | Expired |
| US6933289B2 | Inhibition of irritating side effects associated with use of a topical ophthalmic medication | Human Necessities | 39 | Expired |
| US6391832B2 | Medical emulsion for lubrication and delivery of drugs | Human Necessities | 37 | Expired |
| US6969706B1 | Preserved pharmaceutical compositions comprising cyclodextrins | Emerging Cross-Sectional Technologies | 23 | Expired |
| US6872705B2 | Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions | Human Necessities | 21 | Expired |
| US6281175A | Medical emulsion for lubrication and delivery of drugs | Human Necessities | 13 | Expired |
| US8039010B2 | Sustained release intraocular drug delivery systems comprising a water soluble therapeutic agent and a release modifier | Human Necessities | 13 | Active |
| US8846094B2 | Peripherally administered viscous formulations | Human Necessities | 12 | Active |
| US5635536A | Emulsion suitable for administering a sphingolipid | Human Necessities | 11 | Expired |
| US9089478B2 | Peripherally administered viscous formulations | Human Necessities | 9 | Active |
| US5677341A | Emulsion suitable for administering a sphingolipid | Human Necessities | 9 | Expired |
| US6054421A | Medical emulsion lubricant | Human Necessities | 8 | Expired |
| US8956655B2 | Biodegradable drug delivery system | Human Necessities | 7 | Active |
| US8231892B2 | Biodegradable drug delivery system | Human Necessities | 7 | Active |
| US8318169B2 | Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier | Human Necessities | 7 | Active |
| US8834884B2 | Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier | Human Necessities | 6 | Active |
| US8343949B2 | Stabilized compositions comprising a therapeutically active agent, and an oxidizing preservative | Human Necessities | 5 | Active |
| US8506962B2 | Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier | Human Necessities | 5 | Active |
| US8691802B2 | Stabilized compositions comprising a therapeutically active agent and an oxidizing preservative | Human Necessities | 5 | Active |
| US8642067B2 | Methods and compositions for intraocular administration to treat ocular conditions | Human Necessities | 4 | Active |
| US8512717B2 | Compositions for delivery of therapeutics into the eyes and methods for making and using same | Human Necessities | 4 | Active |
| US8992952B2 | Compositions for delivery of therapeutics into the eyes and methods for making and using same | Human Necessities | 4 | Active |
| US7390318B2 | Needleless microprotrusion elastoplast system | Human Necessities | 4 | Active |
| US4567045A | Isotonic glycerol free intravenous fat emulsion | Human Necessities | 4 | Expired |
| US8569272B2 | Methods for treating a posterior segment of an eye | Human Necessities | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.